Granules India Limited (GRANULES) — Announcement | 6 July 2026

StockFin.ai

Try Free

Granules India announced it secured sole First-to-File status for its ANDA for Sodium Oxybate Extended-Release oral suspension, marking its second such milestone after an earlier complex generic approval. The filing highlights the company's growing capabilities in differentiated generics for the U.S. market and reinforces its focus on innovation and patient access.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GRANULES ✨ Ask AI About This

About Granules India Limited (GRANULES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹18,242.81 Cr P/E: 37.2

View full GRANULES stock details →

📡 Get AI alerts when GRANULES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GRANULES — Free

💡 Ask AI about this filing

"How does this announcement affect Granules India Limited's outlook?" "What did Granules India Limited announce on 6 July 2026?" "Is this positive or negative for GRANULES?"

Ask AI Free →

📊 More GRANULES filings

See all GRANULES filings →

🔥 Also filed on 6 July 2026

PRECWIRE Precision Wires India Limited Announcement PROZONER Prozone Realty Limited Announcement PRUDENT Prudent Corporate Advisory Services Limited Annual Report PRUDENT Prudent Corporate Advisory Services Limited Annual Report PSB Punjab & Sind Bank Annual Report PUNJABCHEM Punjab Chemicals & Crop Protection Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GRANULES files new disclosures

Track GRANULES filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GRANULES — Free

Free account · 2 AI queries/day